Literature DB >> 26841328

Molecular Aberrance in Papillary Thyroid Microcarcinoma Bearing High Aggressiveness: Identifying a "Tibetan Mastiff Dog" From Puppies.

Dapeng Li1, Ming Gao1, Xiaolong Li2, Mingzhao Xing3.   

Abstract

Today the most common differentiated thyroid cancer in many countries is papillary thyroid microcarcinoma (PTMC). Although the majority of PTMCs exhibit an indolent clinical course, a few possess high risk for aggressiveness with tumor invasion, metastasis, and even patient mortality. This imposes significant confusion and often dilemma in the clinical management of PTMC. The present review summarizes the molecular pathogenesis, particularly the major genetic alterations, of PTMC that may have prognostic values in assisting risk stratification of this cancer and identification of the most aggressive cases from the many well-behaving cases. J. Cell. Biochem. 117: 1491-1496, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  BRAFV600E; MUTATION; PAPILLARY THYROID MICROCARCINOMA; TERT; miRNA

Mesh:

Year:  2016        PMID: 26841328     DOI: 10.1002/jcb.25506

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  5 in total

1.  Tescalcin promotes highly invasive papillary thyroid microcarcinoma by regulating FOS/ERK signaling pathway.

Authors:  Xiuhe Zou; Qian Zhou; Yan Nie; Junhe Gou; Jing Yang; Jingqiang Zhu; Zhihui Li; Yanping Gong
Journal:  BMC Cancer       Date:  2022-05-31       Impact factor: 4.638

2.  Mutational profile of papillary thyroid microcarcinoma with extensive lymph node metastasis.

Authors:  Min Ji Jeon; Sung Min Chun; Ji-Young Lee; Kyeong Woon Choi; Deokhoon Kim; Tae Yong Kim; Se Jin Jang; Won Bae Kim; Young Kee Shong; Dong Eun Song; Won Gu Kim
Journal:  Endocrine       Date:  2019-01-15       Impact factor: 3.633

Review 3.  Active Surveillance of Thyroid Microcarcinomas: a Critical View.

Authors:  Claudio R Cernea; Leandro Luongo Matos; Cecília Eugênio; Giovanna Mattos Ferreira; Yasmin Sa Cerqueira; Ana Kober N Leite; Felipe A B Vanderlei; Dorival de Carlucci; Renato N Gotoda; Flávio C Hojaij; Vergilius J F Araújo-Filho
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

4.  2016 Chinese expert consensus and guidelines for the diagnosis and treatment of papillary thyroid microcarcinoma.

Authors:  Ming Gao; Minghua Ge; Qinghai Ji; Ruochuan Cheng; Hankui Lu; Haixia Guan; Li Gao; Zhuming Guo; Tao Huang; Xiaoming Huang; Xiaoming Li; Yansong Lin; Qinjiang Liu; Xin Ni; Yi Pan; Jianwu Qin; Zhongyan Shan; Hui Sun; Xudong Wang; Zhengang Xu; Yang Yu; Daiwei Zhao; Naisong Zhang; Sheng Zhang; Ying Zheng; Jingqiang Zhu; Dapeng Li; Xiangqian Zheng
Journal:  Cancer Biol Med       Date:  2017-08       Impact factor: 4.248

5.  Whole-Exome Sequencing in Papillary Microcarcinoma: Potential Early Biomarkers of Lateral Lymph Node Metastasis.

Authors:  Mijin Kim; Chae Hwa Kwon; Min Hee Jang; Jeong Mi Kim; Eun Heui Kim; Yun Kyung Jeon; Sang Soo Kim; Kyung-Un Choi; In Joo Kim; Meeyoung Park; Bo Hyun Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2021-10-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.